PEG Phospholipids

PEG phospholipids can be applied to liposomal drug formulations to prolong the half-life of plasma circulation in drugs. Coating of the liposomal surface with polyethylene glycol suppresses drug clearance in vivo by the reticuloendothelial system, thereby prolonging the half-life of the drug.
PEG-modified lipids can also be used as emulsifiers and stabilizers of microspheres in aqueous solutions

 

PEG Phospholipids

Activated PEG phospholipids

  1. 1
  2. 2
DSPE-PEG-MAL N-[N'-(3'-Maleimido-1'-oxopropyl) aminopropyl polyoxyethylene oxycarbonyl]-1,2-distearoyl-sn-glycero-3-phosphoethanolamine, sodium salt
DSPE-PEG-MAL N-[N'-(3'-Maleimido-1'-oxopropyl) aminopropyl poly(oxyethylene) oxycarbonyl]-1,2-distearoyl-sn-glycero -3-phosphoethanolamine, sodium salt
DSPE-PEG-MAL N-[N'-(3'-Maleimido-1'-oxopropyl) aminopropyl poly(oxyethylene) oxycarbonyl]-1,2-distearoyl-sn-glycero -3-phosphoethanolamine, sodium salt
DSPE-PEG-NHS N-[N'-(Succinimidyloxy glutaryl) aminopropyl polyoxyethylene oxycarbonyl]-1,2-distearoyl-sn-glycero-3-phosphoethanolamine, sodium salt
DSPE-PEG-NHS N-[N'-(Succinimidyloxy glutaryl) aminopropyl polyoxyethylene oxycarbonyl]-1,2-distearoyl-sn-glycero-3-phosphoethanolamine, sodium salt
DSPE-PEG-NHS N-[N'-(Succinimidyloxy glutaryl) aminopropyl polyoxyethylene oxycarbonyl]-1,2-distearoyl-sn-glycero-3-phosphoethanolamine, sodium salt
DSPE-PEG-ALD N-(3'-Oxopropylpolyoxyethylene oxycarbonyl)-1,2-distearoyl-sn-glycero-3-phosphoethanolamine, sodium salt
  1. 1
  2. 2